Inventor · disambiguated record
Patrice Debre
Also filed as: DEBRE PATRICE
8 granted patents·9 pending applications·31 citations·filing 1991–2022
81Inventor score
Top patents by PatentIndex Score
17 records- 0169US7915221B2Methods for construction and screening of libraries of chemokine variantsUNIV PARIS CURIE·Filed 2007·Granted Mar 29, 2011·1 cites·2 claims
- 0269US7211564B2Methods and construction and screening of libraries of chemokine variantsUNIV GENEVE·Filed 2004·Granted May 1, 2007·5 cites·3 claims
- 0358US10174080B2Compositions for preventing and/or treating an infection by an HIV-1 virusDEBRE PATRICE·Filed 2017·Granted Jan 8, 2019·0 cites·14 claims
- 0458US5246699AMaturation of hemopoietic cellsCIBA GEIGY CORP·Filed 1991·Granted Sep 21, 1993·23 cites·7 claims
- 0556US2025012799A1Sars-cov-2 polypeptides and uses thereofIAMA FRANCE·Filed 2022·Application pending·0 cites
- 0653US9181299B2Compositions for detecting an infection by an HIV-1 virusDEBRE PATRICE·Filed 2012·Granted Nov 10, 2015·0 cites·9 claims
- 0753US8372955B2Purified antibody to the extracellular domain of NKp44LASSIST PUBL HOPITAUX DE PARIS·Filed 2007·Granted Feb 12, 2013·0 cites·5 claims
- 0852US9802983B2Compositions for preventing and/or treating an infection by an HIV-1 virusDEBRE PATRICE·Filed 2015·Granted Oct 31, 2017·0 cites·18 claims
- 0950US2014335119A1POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUALINST NAT SANTE RECH MED·Filed 2014·Application pending·0 cites
- 1050US2009136533A1POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUALINSERM INST NAT DE LA RECH MED·Filed 2009·Application pending·0 cites
- 1145US2006257318A1Method for the in vitro assessment of the progression status of an infection by an hiv virus in an individualASSIST PUBL HOPITAUX DE PARIS·Filed 2004·Application pending·0 cites
- 1244US2017128564A1POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUALINST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM)·Filed 2016·Application pending·0 cites
- 1343US2003049603A1Methods for construction and screening of libraries of chemokine variantsFiled 2001·Application pending·0 cites
- 1438US2014024018A1Method for the prognosis of progression of the hiv diseaseMEYER LAURENCE·Filed 2012·Application pending·0 cites
- 1535US2007092525A1Polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individualASSIST PUBL HOPITAUX DE PARIS·Filed 2005·Application pending·0 cites
- 1634US2005074463A1Therapeutic vaccination method, mutated peptides of hiv reverse transciptase and their use for vaccination and diagnostic purposesUNIV PARIS CURIE·Filed 2001·Application pending·0 cites
- 1727US5236706APharmaceutical preparation for the maturation of prothymocytesCIBA GEIGY CORP·Filed 1991·Granted Aug 17, 1993·2 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Patrice Debre files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →